Medication:

 

Letrozole (aromatase inhibitor): ER+PR+ BC

IBRANE (Palbociclib, CDK inhibitor): HER2 – BC

Verzenio (Abemaciclib, CDK inhibitor): Breast cancer and ovarian cancer

Kispali (Ribociclib, CDK 4,6 inhibitors): Breast cancer and ovarian cancer

Combination of Letrozole and CDK inhibitor has better response.

Keytruda (pembrolizumab): PD-L1 and HER 2+/- lung cancer, GI cancer, bladder cancer

Abemaciclib (immunotherapy for BC, Verizenio 150mg Po) -SE diarrhea

Ribociclib (immunotherapy for BC, Kisquli)-SE constipation 

Tamoxifen (young pre meno) and Raloxifene (post-meno): prevent BC by suppression after surgery/ chemo/irradiation

Leuprolide (GnRH agonist): Prostate cancer

Trastuzumab (anti-EGFR monoclonal antibody): HER 2+ BC

Rituximab (anti-CD 20): NHL, CLL, RA, MS, TIP, AIHA, TTP

Taxanes: BC, Ovarian cancer

Humira (Adalimumab- TNF-alpha blocker): RA, Crohn’s, UC, Psoriatic RA, AK

Nupogen (GN CSF): Chemo induced neutropenia 

FOLFOX (FOL, leucovorin calcium, F, fluorouracil, OX, oxaliplatin), + Avastin, FOLFIRI, Lonsurf (po pill): colon cancer 

Imbruvia (BTK inhibitor): WM

Enhertu (fam-trastuzumab deruxtecan-niki) IV: HER2+ cancer. BC, NSCLC, GI cancer. Side effect ILD, managed with steroid 

OPDIVO (nivolumab): upper GI cancer, thyroid cancer, etc

IV OPdualog (Nivolumab + relatimab): Metastatic Melanoma

Cabometyx (TKI, cabocantinib) and Opdivo (OI, nivoluma): Clear renal cell carcinoma, refractory

Eportamab: DLBCL (diffuse large B cell lymphoma)

Capecitabine oral pill (pro drug of 5FU): Start early to prevent cancer growth, GI and breast cancer

Zoledronic acid: osteoporosis for MM, BC, and Prostate cancer 

NGS next generation sequence genetic test

OPDIVO (nivolumab): gastric cancer, thyroid cancer

OPdualog (nivolumab and pelatimab)-PD-L1 metastatic melanoma

Repolrectinib (oral): ROS 1 NSCLcancer

Eporitamab: 3L + DLBCL

Capecitabine (oral): start early to prevent Breast cancer and GI cancer from growing